Insights
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
The glucagon-like peptide-1 (GLP-1) receptor agonist market is experiencing rapid growth, with more than 150 drug candidates currently in development as reported by Research & Markets,…
Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next
10 April 2025
As part of EuroQol’s current priority-setting work, the development of bolt-ons for the EQ-5D-5L instrument has taken centre stage. A “bolt-on toolbox” is being developed to…
Around the World in HTAs: Canada – Autonomous yet Collaborative
9 April 2025
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Adam Raymakers and Chris Skedgel take us to Canada.
Advancing Rare Disease Care: Challenges and Key Issues
28 February 2025
Today marks Rare Disease Day 2025. This time last year we published an Article entitled “ Why do we care about rare?”, summarising the origins of…
EQ-5D and beyond: OHE’s contributions to EuroQol research and meetings
27 February 2025
Measuring and valuing health outcomes is arguably what makes health economics such a unique and sometimes controversial discipline. The idea of putting a numerical value on…
Driving Green Change: Lessons from the 2024 Innovation Policy Prize
5 February 2025
Last week, the OHE Innovation Policy Prize was jointly awarded to Professor Andrew Briggs and Professor Thomas Pogge.
Infectious disease: another reason to try Veganuary for the NHS
30 January 2025
We dust off last year’s model to consider the potential savings to the NHS from more people going vegan, with a focus on COVID-19.
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
This Insight summarises the recommendations OHE submitted towards the Department of Health & Social Care’s consultation on the next 10 years of planning for the NHS.
Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives
26 November 2024
To help inform the current debate on assisted dying, we have updated the findings of our 2019 palliative report with the latest data.